Diagnostic Value of the Combination of Serum TH1/TH2 Cytokines, Procalcitonin, and High-sensitivity C-reactive Protein for Predicting the Severity of Pneumonia
Abstract
T helper 1 (TH1) and T helper 2 (TH2) cells can secrete various proinflammatory and anti-inflammatory factors, which can serve as indicators for predicting the severity of pneumonia.However, they are rarely used in combination with procalcitonin (PCT) and high-sensitivity C-reactive protein (hsCRP) detection to predict the severity of pneumonia. The purpose of this studyis to investigate the combination of serum TH1/TH2 cytokines, PCT, and hsCRP for predicting theseverity of community-acquired pneumonia (CAP).This study observed 58 inpatients with CAP. Analyses were conducted on the serum levels ofTH1/TH2 cytokines, PCT, and hsCRP; imaging examination results; underlying diseases; pathogens;and the pneumonia severity index (PSI).The severe pneumonia group showed significantly higher PSI scores, age, and complicationrates. Serum IL-2 was notably elevated in severe cases, while a combination of PCT, IL-4, TNF-α,and IFN-γ effectively predicted severe pneumonia, with an AUC of 0.712. Specific alterations incytokines and biomarkers were identified as risk factors for higher PSI, complications, andprolonged hospitalization.The combined detection of PCT, IL-4, TNF-α, and IFN-γ provides a potential tool forpredicting severe CAP, and distinct biomarker profiles are associated with different clinicaloutcomes